Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market The global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market was valued at USD 498 Million in 2018 and is expected to reach USD 783 Million by year 2026, at a CAGR of 5.8 %. High target disease prevalence, product launches, increasing strategic developments such as partnerships and agreements, favorable research […]
